Welcome to our dedicated page for Charlie S Holdin SEC filings (Ticker: CHUC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Charlie’s Holdings, Inc. (OTCQB: CHUC), a company operating in the premium vapor products space. These regulatory documents offer detailed information on the company’s financial condition, operations, and risk disclosures beyond what appears in press releases or marketing materials.
Charlie’s SEC filings include periodic reports such as Forms 10-K and 10-Q, which describe revenue, expenses, liquidity, and key business developments for its SBX, PACHA, and Pachamama 25K product lines. For example, the company has filed a Form 12b-25 (Notification of Late Filing) related to a Quarterly Report on Form 10-Q for the period ended September 30, 2025, explaining that additional time was needed for compilation and review to ensure adequate disclosure. Such filings help investors understand the timing and completeness of the company’s financial reporting.
Other SEC filings may cover topics such as capital structure changes, credit facilities, or material agreements, including arrangements that support SBX inventory purchases or the monetization of PMTA assets tied to PACHA synthetic nicotine products. Together, these documents outline how Charlie’s finances its operations, manages regulatory obligations, and accounts for income from strategic partnerships.
On Stock Titan, Charlie’s filings are updated as they are made available through the EDGAR system. AI-powered summaries help explain lengthy or technical sections of annual and quarterly reports, highlighting items such as segment performance, regulatory disclosures, and risk factors in more accessible language. Users can also review insider transaction reports on Form 4, if filed, to see reported purchases or sales of Charlie’s securities by officers, directors, or significant shareholders.
By combining real-time access to Charlie’s SEC filings with AI-generated explanations, this page is intended to make it easier to understand how the company reports its financial results, regulatory status, and key corporate actions over time.
Charlie’s Holdings, Inc. (CHUC) reported a sharp improvement in results for the nine months ended September 30, 2025. Net product revenue rose to $11.9 million from $6.7 million, while gross profit increased to $3.0 million. The company generated net income of $4.4 million versus a $3.0 million loss a year earlier, largely driven by a $7.5 million gain on the sale of PACHA synthetic products and related PMTA assets to R.J. Reynolds Vapor Company.
Cash increased to $1.2 million, and working capital swung to a $3.1 million surplus from a deficit, but operating activities used $6.2 million of cash. Management still cites substantial doubt about the company’s ability to continue as a going concern without additional revenue growth or financing. At September 30, 2025, stockholders’ equity improved to $3.2 million, and common shares outstanding were 270.6 million.
Strategically, Charlie’s is pushing Metatine-based SBX disposable vapes and other alternative alkaloid products, securing more than $6 million in purchase orders at the October 2025 NACS show, including a single $4.4 million SBX order. The company also received an FDA Marketing Denial Order on certain PMTAs but obtained a temporary administrative stay from a federal appeals court and plans to contest the decision. The Don Polly variable interest entity will be wound down.
Charlie’s Holdings, Inc. filed a Form 12b-25 to notify a late filing of its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2025. The company says it needs additional time to compile and review information to ensure adequate disclosure. It anticipates filing the Form 10-Q on or before the fifth calendar day following the prescribed due date.